Is current body temperature measurement practice fit-for-purpose?


Journal

Journal of medical engineering & technology
ISSN: 1464-522X
Titre abrégé: J Med Eng Technol
Pays: England
ID NLM: 7702125

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 27 2 2021
medline: 24 3 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

There has been a marked rise in the number of avoidable deaths in health services around the world. At the same time there has been a growing increase in antibiotic resistant so-called "superbugs." We examine here the potential role of body temperature measurement in these adverse trends. Electronic based thermometers have replaced traditional mercury (and other liquid-in-glass type) thermometers for reasons of safety rather than superiority. Electronic thermometers are in general less robust from a measurement perspective than their predecessors. We illustrate the implications of unreliable temperature measurement on the diagnosis and management of disease, including COVID-19, through statistical calculations. Since a return to mercury thermometers is both undesirable and impractical, we call for better governance in the current practice of clinical thermometry to ensure the traceability and long-term accuracy of electronic thermometers and discuss how this could be achieved.

Identifiants

pubmed: 33632055
doi: 10.1080/03091902.2021.1873441
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

136-144

Auteurs

Graham Machin (G)

National Physical Laboratory, Teddington, UK.

David Brettle (D)

Medical Physics, Leeds Teaching Hospitals NHS trust, Leeds, UK.

Susannah Fleming (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Rebecca Nutbrown (R)

Department of Medical Physics, Royal Surrey NHS Foundation Trust, Surrey, UK.

Rob Simpson (R)

National Physical Laboratory, Teddington, UK.

Richard Stevens (R)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Mark Tooley (M)

Office of the Chief Scientific Officer, Medical Directorate, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH